Table 1.
Cohort description
| Patient Details | Total (n = 132) |
|---|---|
| Age at diagnosis: mean years (SD ±) | 53.3 (SD ±13.6) |
| Time to recurrence: mean months (SD ±) | 38.7 (SD ±27.7) |
| Recurrence location | |
| Loco-regional | 58 (44%) |
| Distal | 74 (56%) |
| Neoadjuvant Chemo Rx | |
| Received | 58 (44%) |
| Did not receive | 74 (56%) |
| Surgery | |
| Mastectomy | 83 (62.8%) |
| Wide local excision | 49 (37.2%) |
| Survival: Months | |
| Overall: mean (SD ±) | 60 (38.3) |
| Post-recurrence survival: mean (SD ±) | 20.7 (21.1) |
| Original subtype | |
| Luminal A | 67 (50.7%) |
| Luminal B | 10 (7.5%) |
| HER2 | 15 (11.3%) |
| Triple negative | 40 (30.5%) |
| Recurrence subtype | |
| Luminal A | 54 (40.9%) |
| Luminal B | 9 (6.9%) |
| HER2 | 16 (12.1%) |
| Triple negative | 53 (40.1%) |